Skip to main content
SpringerLink
Log in

Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan

  • Letter to the Editor
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Onoue M, Terada T, Kobayashi M et al (2009) UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients. Int J Clin Oncol 14:136–142

    Article  CAS  PubMed  Google Scholar 

  2. Hoskins JM, Goldberg RM, Qu P et al (2007) UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 99:1290–1295

    Article  CAS  PubMed  Google Scholar 

  3. Takano M, Kato M, Yoshikawa T et al (2009) Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study. Oncology 76:315–321

    Article  CAS  PubMed  Google Scholar 

  4. Ichikawa W, Araki K, Fujita K et al (2008) Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 100:224–225

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

No author has any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan

    Masashi Takano, Masafumi Kato, Tomoyuki Yoshikawa, Tomoko Goto & Kenichi Furuya

  2. Department of Gynecology, Ohki Memorial Kikuchi Cancer Clinic for Women, Tokorozawa, Saitama, 359-1133, Japan

    Yoshihiro Kikuchi

Authors
  1. Masashi Takano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masafumi Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoyuki Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoko Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenichi Furuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshihiro Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masashi Takano.

About this article

Cite this article

Takano, M., Kato, M., Yoshikawa, T. et al. Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan. Int J Clin Oncol 15, 224–225 (2010). https://doi.org/10.1007/s10147-010-0024-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-010-0024-2

Keywords

Search

Navigation